Detalles de la búsqueda
1.
Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects.
Antimicrob Agents Chemother
; 61(1)2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27799203
2.
Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects.
J Antimicrob Chemother
; 72(3): 820-828, 2017 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27999038
3.
Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.
J Infect Dis
; 209(1): 12-23, 2014 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24041789
4.
Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice.
Virol J
; 11: 70, 2014 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24739285
5.
A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies.
J Infect Dis
; 205(1): 28-34, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22090447
6.
ABX464 (obefazimod) for patients with COVID-19 at risk for severe disease: miR-AGE, a randomized, double-blind placebo-controlled trial.
J Allergy Clin Immunol Glob
; 2(4): 100140, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37781656
7.
A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals.
Clin Infect Dis
; 54(7): 946-54, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22267715
8.
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial.
Lancet
; 377(9767): 751-9, 2011 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21329971
9.
Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza.
Transfusion
; 52(4): 803-9, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21981280
10.
A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
J Infect Dis
; 203(11): 1556-64, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21592984
11.
Demonstration of the Antitumor Activity of the iNKT Agonist ABX196, a Novel Enhancer of Cancer Immunotherapy, in Melanoma and Hepatocarcinoma Mouse Models.
Mol Cancer Ther
; 21(12): 1788-1797, 2022 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36198025
12.
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension.
Lancet Gastroenterol Hepatol
; 7(11): 1024-1035, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36075249
13.
A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.
N Engl J Med
; 358(24): 2573-84, 2008 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-18550874
14.
Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitability.
Semin Thromb Hemost
; 36(5): 522-8, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20632249
15.
Structure and function of a recombinant von Willebrand factor drug candidate.
Semin Thromb Hemost
; 36(5): 510-21, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20635317
16.
A close look at human IgG sialylation and subclass distribution after lectin fractionation.
Proteomics
; 9(17): 4143-53, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19688751
17.
Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
Hum Vaccin
; 5(8): 551-6, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19430202
18.
Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study.
J Virus Erad
; 5(1): 10-22, 2019 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30800421
19.
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients.
Clin Vaccine Immunol
; 21(6): 867-76, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24739978
20.
Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development.
Expert Rev Vaccines
; 12(4): 395-413, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23560920